Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates
Top Cited Papers
- 21 February 2013
- journal article
- research article
- Published by Elsevier BV in Cell Chemical Biology
- Vol. 20 (2), 161-167
- https://doi.org/10.1016/j.chembiol.2013.01.010
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Synthesis of site-specific antibody-drug conjugates using unnatural amino acidsProceedings of the National Academy of Sciences of the United States of America, 2012
- Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugatesNature Biotechnology, 2012
- Site‐Specific and Stoichiometric Modification of Antibodies by Bacterial TransglutaminaseAngewandte Chemie, 2010
- Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast CancerClinical Cancer Research, 2010
- Effect of temperature, pH, dissolved oxygen, and hydrolysate on the formation of triple light chain antibodies in cell cultureBiotechnology Progress, 2010
- Identification and Localization of Unpaired Cysteine Residues in Monoclonal Antibodies by Fluorescence Labeling and Mass SpectrometryAnalytical Chemistry, 2009
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic indexNature Biotechnology, 2008
- Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment"Protein Engineering, Design and Selection", 2006
- Structural characterization of the maytansinoid–monoclonal antibody immunoconjugate, huN901–DM1, by mass spectrometryProtein Science, 2005
- Synthesis and Antitumor Activity of Novel Dolastatin 10 Analogs.CHEMICAL & PHARMACEUTICAL BULLETIN, 1995